Table 2.
Biomarker | AUROC | Std. error | 95% confidence interval | P value |
---|---|---|---|---|
Blood/conventional | ||||
BUN | 0.6368 | 0.07728 | 0.4853–0.7882 | 0.0486 |
sCre | 0.5692 | 0.06723 | 0.4375–0.701 | 0.3385 |
Urinary protein | ||||
IP-10 | 0.8015 | 0.0567 | 0.6903–0.9126 | <0.0001 |
Renin | 0.7334 | 0.07199 | 0.5923–0.8745 | 0.0013 |
NGAL | 0.6962 | 0.0711 | 0.5569–0.8356 | 0.0054 |
B2M | 0.6251 | 0.07968 | 0.4689–0.7813 | 0.0847 |
Clusterin | 0.6062 | 0.07064 | 0.4677–0.7446 | 0.1333 |
Osteopontin | 0.5827 | 0.07393 | 0.4378–0.7276 | 0.2422 |
KIM-1 | 0.5771 | 0.07733 | 0.4256–0.7287 | 0.2879 |
Cystatin C | 0.5683 | 0.07173 | 0.4277–0.7089 | 0.3326 |
TIMP-1* | 0.5833 | 0.1099 | 0.3679–0.7988 | 0.4516 |
VEGF | 0.5236 | 0.07896 | 0.3689–0.6784 | 0.7506 |
EGF | 0.5087 | 0.07218 | 0.3672–0.6502 | 0.902 |
Urinary miRNA | ||||
miR-685 | 0.8234 | 0.05461 | 0.7163–0.9304 | 0.0001 |
miR-138 | 0.8108 | 0.06258 | 0.6882–0.9335 | 0.0004 |
miR-218 | 0.7891 | 0.05807 | 0.6752–0.9029 | 0.0007 |
miR-221 | 0.769 | 0.06628 | 0.6391–0.8989 | 0.0014 |
miR-680 | 0.7649 | 0.06285 | 0.6418–0.8881 | 0.0017 |
miR-320 | 0.7595 | 0.06793 | 0.6264–0.8927 | 0.0021 |
miR-130a | 0.7486 | 0.06136 | 0.6284–0.8689 | 0.0032 |
miR-151-3p | 0.7473 | 0.07087 | 0.6084–0.8862 | 0.0034 |
miR-328 | 0.7351 | 0.07534 | 0.5874–0.8827 | 0.0054 |
miR-152 | 0.7133 | 0.06969 | 0.5767–0.8499 | 0.0115 |
AUROC: area under the ROC; BUN: blood urea nitrogen; B2M: β2-microglubulin; EGF: epidermal growth factor; IP-10: interferon gamma-induced protein 10; KIM-1: kidney injury molecule-1 (KIM-1), albumin; NGAL: neutrophil gelatinase-associated lipocalin; ROC: receiver-operating characteristic; TIMP-1: TIMP metalloprotease inhibitor 1; VEGF: vascular endothelial growth factor.
Within each biomarker category, markers are sorted by AUROC value from highest to lowest.
*Several values for TIMP-1 in both the vehicle- and cisplatin-treated mice were below the lower limit of quantification; therefore, these data should be interpreted with caution.